Rachid Rafia

ORCID: 0000-0002-6914-1990
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Breast Cancer Treatment Studies
  • Substance Abuse Treatment and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Pharmaceutical Economics and Policy
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Breast Implant and Reconstruction
  • Global Cancer Incidence and Screening
  • Lung Cancer Treatments and Mutations
  • Alcohol Consumption and Health Effects
  • Renal cell carcinoma treatment
  • Sarcoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Healthcare Policy and Management
  • Clinical practice guidelines implementation
  • Ovarian cancer diagnosis and treatment
  • Statistical Methods in Clinical Trials
  • Sepsis Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Spondyloarthritis Studies and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Hepatitis B Virus Studies
  • BRCA gene mutations in cancer

University of Sheffield
2012-2022

New York University Press
2017

Cambridge University Press
2017

Royal Australasian College of Surgeons
2017

The University of Adelaide
2017

Clinical Orthopaedics and Related Research
2010

University Hospital of Wales
2010

Cardiff University
2010

Addenbrooke's Hospital
2010

Perth Royal Infirmary
2009

Aims: To estimate the cost-effectiveness and resourcing implications of universal alcohol screening brief intervention (SBI) programmes in primary care England. Methods: This was a health economic model, combining evidence effectiveness resource requirements SBI activities with existing epidemiological modelling relationship between consumption harms. Results: Screening patients on registration family doctor would steadily capture ∼40% population over 10-year programme; at next consultation...

10.1093/alcalc/ags103 article EN Alcohol and Alcoholism 2012-09-25

This methodology paper sets out a mathematical description of the Sheffield Alcohol Policy Model version 2.0, model to evaluate public health strategies for alcohol harm reduction in UK. Policies that can be appraised include minimum price per unit alcohol, restrictions on discounting, and broader measures. The estimates impact consumers, services, crime, employers, retailers government tax revenues. synthesis commercial data sources inform structure is described. A detailed algebraic...

10.1002/hec.3105 article EN cc-by Health Economics 2014-09-30

ABSTRACTObjective: Based on positive safety and efficacy data, a quadrivalent Human PapillomaVirus (HPV) vaccine has been approved in Switzerland to prevent HPV types 6, 11, 16 18 infections. The objective of this study was explore the cost-effectiveness an vaccination Switzerland.Design methods: A Markov model natural history infection adapted Swiss context followed hypothetical cohort 41 200 girls aged 11 years over their lifetime. Main epidemiological economic parameters were extracted...

10.1185/030079908x297826 article EN Current Medical Research and Opinion 2008-04-14

Objectives. The primary aim of this study was to estimate annual health care costs for biologic-naïve patients with PsA in the UK. relationship between disease severity, defined by physical limitations, and also explored. Methods. This utilized data from British Society Rheumatology Biologics Register (BSRBR) develop a multivariate model estimating severity parameters available routine data. HAQ Disability Index used determine severity. algorithm then applied Health Improvement Network...

10.1093/rheumatology/keq182 article EN Lara D. Veeken 2010-06-26

This paper sets out the development of a methodological framework for detailed evaluation public health strategies alcohol harm reduction to meet UK policy-makers needs. Alcohol is known cause substantial harms, and controlling its affordability availability are effective policy options. Analysis synthesis variety commercial data sources needed evaluate impact on consumers, services, crime, employers industry, so sound important. We discuss iterative process engage with stakeholders,...

10.1007/s10479-013-1451-z article EN cc-by Annals of Operations Research 2013-10-07

Diabetes is associated with premature death and a number of serious complications. The presence comorbid depression makes these outcomes more likely results in increased healthcare costs. aim this work was to assess the health economic having both diabetes depression, cost-effectiveness potential policy changes improve care pathway: improved opportunistic screening for collaborative treatment, combination both.A mathematical model pathways experienced by people diagnosed type-2 England...

10.1186/s12913-017-2003-z article EN cc-by BMC Health Services Research 2017-01-24

Background: While evidence shows high-dose statins reduce cardiovascular events compared with moderate doses in individuals acute coronary syndrome (ACS), many primary care trusts (PCT) advocate the use of generic simvastatin 40 mg/day for these patients. Methods and results: Data from 28 RCTs were synthesized using a mixed treatment comparison model. A Markov model was used to evaluate cost-effectiveness treatments taking into account adherence likely reduction cost atorvastatin when patent...

10.1177/1741826711406616 article EN European Journal of Preventive Cardiology 2011-04-01

Aims To determine whether the provision of contingency management using financial incentives to improve hepatitis B vaccine completion in people who inject drugs entering community treatment represents a cost-effective use health-care resources. Design A probabilistic cost-effectiveness analysis was conducted, decision-tree estimate short-term clinical and cost impact vaccination strategies, followed by Markov process evaluate long-term consequences costs associated with infection. Settings...

10.1111/add.13385 article EN cc-by-nc Addiction 2016-03-19

Objective and Methods: A decision analytic model was built to assess the paediatric rotavirus gastroenteritis (RVGE) burden potential benefits associated with introduction of RotaTeq®† (pentavalent vaccine) in Belgium.Results: In absence a (RV) immunisation programme, RVGE estimated account for about 5,860 hospitalisations, 1,720 cases nosocomial infections, 9,410 treated by general practitioners/paediatricians (GP/P) 10,790 not seeking medical care birth cohort followed up 5 years age....

10.3111/13696990802306162 article EN Journal of Medical Economics 2008-01-01
Coming Soon ...